The Omega-3 Index and Heart Risk: What Cohort Research Shows
What the Omega-3 Index is and what cohort studies found about blood omega-3 levels, heart disease and death, plus the limits of observational research and testing.
Content last updated . This page has not been medically reviewed.
The Omega-3 Index is the percentage of EPA plus DHA in red blood cells, used as a marker of longer-term intake. [1] [2] In observational studies, people with higher blood levels of long-chain omega-3 had lower rates of fatal heart disease and death. [3] [4] That is an association: such studies cannot show that raising the number with a supplement lowers risk. This page is information, not advice, and a clinician decides whether any test is useful.
How to read the labels
"Observational" means researchers measured people and followed them, with no assigned treatment. "Mixed" means results differ by group or measure. "Insufficient evidence" means too little to say. A blood level is a biomarker, not a clinical outcome.
What the Omega-3 Index is
A 2004 paper proposed the red-blood-cell EPA plus DHA as a risk marker for death from coronary heart disease. [1] It said red blood cell fatty acids reflect long-term intake of EPA plus DHA. [1] A 2023 review describes the Omega-3 Index as the percentage of EPA plus DHA in erythrocytes (red blood cells) measured by a specific standardised procedure. [2] Other studies in this page measured omega-3 in plasma, phospholipids or other tissues, so numbers are not always comparable. [3]
What cohort research found
| Question | What the source found | Strength |
|---|---|---|
| Sudden death in healthy men (Physicians' Health Study) | Baseline blood levels of long-chain n-3 fatty acids were inversely related to risk of sudden death in 94 cases and 184 matched controls. [5] | Older nested case-control study, men only |
| Coronary disease, 19 cohorts | Higher biomarkers of ALA, DPA and DHA were linked to a lower risk of fatal coronary heart disease; no significant link with nonfatal heart attack. [3] | Pooled cohorts; modest association |
| Death from any cause, 17 cohorts | Over a median 16 years, 15,720 deaths occurred among 42,466 people; the highest versus lowest fifth for EPA, DPA and DHA had 15-18% lower risk of death from all causes. [4] | Pooled cohorts; association |
| Level at which risk seems lowest | The 2004 paper reported greatest cardioprotection at an index of 8% or more and least at 4% or less. [1] | Hypothesis from earlier studies |
In the 19-cohort analysis, EPA, ALA and DHA were not all linked to total coronary disease, so results differ by fatty acid and outcome. [3] In the 17-cohort analysis, no associations were seen with the plant omega-3 ALA. [4]
Limits and uncertainty
- Association is not proof of benefit. NCCIH notes that people who eat seafood have generally healthier lifestyles, so other habits may explain part of a link. [6] Randomized trials of supplements did not consistently show fewer heart events: a Cochrane review found little or no effect of increasing EPA and DHA on cardiovascular events. [7] See omega-3 evidence by use.
- Testing supplement strategies. Proper evidence not found: none of the sources we read report a randomized trial showing that supplementing to reach a target Omega-3 Index lowers heart events.
- Author interests. The 2023 review reports that its first author operates a laboratory for fatty acid analyses. [2] Some authors of the 17-cohort paper list consulting for omega-3 industry groups. [4] Read advocacy for testing with that in mind.
- Not interchangeable with intake. EPA and DHA are present in every human being at unpredictable levels, according to that review. [2] A single result can differ by lab method and may change with diet, so interpretation belongs with a clinician.
- Claims on commercial test kits are checked on the science and tools pages of this library, not here.
Safety and who should ask first
- A target number does not tell anyone to take more. Higher amounts carry risks such as atrial fibrillation in some trials: fish oil and atrial fibrillation.
- Omega-3 products can interact with blood thinners: medication interactions. Never change a prescribed medicine on a test result alone.
- For testing in general see deficiency testing and its limits. For labels see how to read a fish oil label.
Frequently asked questions
What is a good Omega-3 Index?
We did not find an official body setting a target. A 2004 paper reported least protection at 4% or less and most at 8% or more, and a 2023 review (whose first author operates a fatty acid laboratory) cites a target range of 8-11%. [1] [2]
Does a low index mean I need a supplement?
The sources do not say so. Observational links do not show that supplements change risk. [7]
Is the Omega-3 Index the same as a fish oil blood test?
Studies measured omega-3 in different samples (red cells, plasma, phospholipids), so numbers are not always comparable. [3]
Does a high level protect against heart disease?
Cohorts linked higher levels to lower rates of fatal coronary disease and death, but that is association. [3] [4]
Can I rely on a home test kit?
Proper evidence not found: the sources we read do not evaluate home kits. Ask a clinician before acting on any result.
References
- The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 2004. Read 2026-10-22.
- Omega-3 fatty acids in heart disease: why accurately measured levels matter. Neth Heart J 2023. Read 2026-10-22.
- ω-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies. JAMA Intern Med 2016. Read 2026-10-22.
- Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies. Nat Commun 2021. Read 2026-10-22.
- Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002. Read 2026-10-22.
- National Center for Complementary and Integrative Health (US), Omega-3 Supplements: What You Need to Know. Last updated November 2024. Read 2026-10-22.
- Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 2018. Read 2026-10-22.